BioSpace News Archive

Drug Development

NicOx SA Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR

June 13, 2008
·
6 min read
UltraShape Ltd. Commences Pivotal Study for First Non-Invasive Fat Reduction and Body Contouring Device Using Non-Thermal Selective Focused Ultrasound

June 13, 2008
·
5 min read
Drug Development

Altus Pharmaceuticals Inc. Reports Last Patient Visit of TrizytekTM Phase 3 Efficacy Trial

June 13, 2008
·
1 min read
Stirling Products Launches Companion Animal Health Initiative at BIO 2008 International Convention

June 13, 2008
·
1 min read
Genetown

Idera Pharmaceuticals, Inc. to Present at BIO Business Forum 2008

June 13, 2008
·
1 min read
Drug Development

VIVUS, Inc. Announces Presentation of Qnexa Data at the 2008 BIO International Convention

June 13, 2008
·
1 min read
Business

Business Wire and EuroBiO Sign Partnership for THE Life Sciences Event of the EU Presidency

June 13, 2008
·
1 min read
Drug Development

Gilead Sciences, Inc. Announces Interim 12-Month Phase III Study Results for Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis; Aztreonam Lysine Well Tolerated

June 13, 2008
·
10 min read
Drug Development

Inspire Pharmaceuticals, Inc.'s Phase 3 CF Trial, Using PARI’s Nebulizer & Compressor, Shows Positive Top-Line Results

June 13, 2008
·
2 min read
Business

Somaxon Pharmaceuticals, Inc. Appoints Erle T. Mast and Thomas G. Wiggans to Its Board of Directors

June 13, 2008
·
1 min read